Interferon-beta-1a FBS-free/HSA-free ( DrugBank: Interferon-beta-1a, Interferon-beta )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00110396 (ClinicalTrials.gov)	January 2005	6/5/2005	Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis	A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate the Safety and Antigenicity of Rebif® (Interferon-beta-1a) in Subjects With Relapsing Forms of Multiple Sclerosis	Multiple Sclerosis	Biological: Interferon-beta-1a FBS-free/HSA-free	EMD Serono	Pfizer	Completed	18 Years	60 Years	All	260	Phase 3	United States